Guest writer Anita Newton shares how she's been coping with grief in the years since her husband, Craig, passed away due to ALS.

Faced with stress and brain fog, columnist Juliet Taylor thought that staying on top of things would keep her husband's ALS ...

The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Clene is scheduled to meet with the FDA in the coming months to discuss new data for CNM-Au8, its experimental oral therapy ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

Shionogi plans to acquire global rights to Radicava and Radicava ORS for ALS through a new U.S. business formed by Tanabe ...

The ALS Association is urging members of Congress to take action to address issues with instability in leadership at the NIH.

Even after 15 years with her husband's ALS, losing caregivers still brings about grief and stress for columnist Kristin Neva.

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

For columnist Dagmar Munn, using the momentum of "swingtime" is helping her manage ALS-related stress and get through tasks.

ALS patients and their caregivers benefit most from flexible psychological support that combines emotional care, open ...